Ananym Capital Management LP Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Ananym Capital Management LP purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 471,507 shares of the company's stock, valued at approximately $32,628,000. Henry Schein makes up approximately 17.9% of Ananym Capital Management LP's portfolio, making the stock its 2nd biggest holding. Ananym Capital Management LP owned 0.38% of Henry Schein at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Olstein Capital Management L.P. grew its holdings in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after buying an additional 16,000 shares in the last quarter. Private Management Group Inc. grew its holdings in shares of Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after buying an additional 18,882 shares in the last quarter. Equitable Trust Co. bought a new position in Henry Schein in the fourth quarter valued at approximately $417,000. Savant Capital LLC increased its position in shares of Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after purchasing an additional 3,650 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HSIC shares. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barrington Research dropped their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Finally, Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company's stock.

Henry Schein Stock Performance

NASDAQ:HSIC traded up $2.24 during mid-day trading on Tuesday, hitting $73.89. 756,661 shares of the stock were exchanged, compared to its average volume of 1,732,639. The firm's 50-day simple moving average is $67.47 and its 200 day simple moving average is $71.56. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $8.99 billion, a price-to-earnings ratio of 30.40, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the company earned $1.10 EPS. The company's revenue was down .1% on a year-over-year basis. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.